Navigation Links
ControlRad Adds Industry-Veteran Chris Fair to its Executive Management Team

ControlRad, LLC, a privately-held medical technology company, focused on dramatically reducing the amount of radiation exposure during fluoroscopically guided procedures, is pleased to announce that Chris Fair has joined its senior management team as Executive Vice President and President of the Mobile C-arm business.

Mr. Fair has been a leader in the musculoskeletal and regenerative marketplace for over 25 years including taking part in several successful exits. Most recently, Mr. Fair was the Chief Executive Officer of Spinal Elements, a Kohlberg & Company operating company focused in the spinal implant marketplace.

“Chris is an outstanding addition to our team,” says Guillaume Bailliard, ControlRad CEO. “As we move into an accelerated growth mode, Chris’ background in building successful medical device companies will be a major asset. Chris will be responsible for building the mobile C-arm business, among other key corporate initiatives.”

“I am honored to join Guillaume and his team to help build a rock-solid foundation for sustainable and scalable success. ControlRad is perfectly positioned to change the lives of thousands of patients and medical staff around the world. I am excited to have the opportunity to help make such a profound difference,” says Mr. Fair. “In my career, I have seen a few technologies at an early stage that you know will significantly impact the health and safety of so many lives. ControlRad’s platform does that as well as provides unparalleled protection to nurses and surgeons treating the patient.”

Chris currently sits on the Parker H Petit Institute for Bioengineering and Bioscience Advisory Board of the Georgia Institute of Technology as well as several privately held medical and regenerative medicine technology companies. Mr. Fair graduated from the University of Richmond Robins School of Business.

About ControlRad
ControlRad is a privately held medical technology company developing innovative products that dramatically reduce the lifetime risk of radiation exposure from fluoroscopically guided procedures (FGP) for patients and healthcare professionals. These products are designed to improve safety without compromising image quality or workflow. This is accomplished with an integrated set of proprietary components, which optimize the X-ray beam to deliver optimal image quality in the clinically-relevant region while maintaining appropriate resolution in the periphery. ControlRad is headquartered in Philadelphia and has engineering development facilities in Kfar Saba, Israel. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related medicine technology :

1. ControlRad Systems Names Industry Leader, Guillaume Bailliard, as CEO
2. ControlRad Systems Continues to Strengthen Its Patent Portfolio with Approval of Fourth Patent
3. Paul Mirabella, former GE Healthcare Officer, Joins ControlRad Systems Board of Directors
4. Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio
5. Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer
6. Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer
7. Axess Ultrasound Selects Christine Wright as Executive Director
8. Chris Newmarker joins MPMN and Qmed
9. Hanger Announces Appointment of Christopher B. Begley to Board of Directors
10. Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
11. The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment
Post Your Comments:
(Date:6/19/2019)... STATE COLLEGE, Pa. (PRWEB) , ... June 19, ... ... leader in nuclear receptor and in vitro toxicology testing solutions, announced the addition ... portfolio. This kit expands INDIGO’s existing in vitro toxicology offerings and allows researchers ...
(Date:6/18/2019)... ... June 18, 2019 , ... The dentists of ... in the Bridgeville, PA area. Understanding the crippling effects patients experience when it ... and Tyler Porco offer same-day oral sedation, nitrous oxide, and IV sedation at ...
(Date:6/16/2019)... ... June 15, 2019 , ... Celiac ... global population. The condition is characterized by damage to the small intestine ... disease, anemia, osteoporosis, fertility problems and some cancers, to name just a few. ...
Breaking Medicine Technology:
(Date:6/20/2019)... ... June 20, 2019 , ... ... company of Chicago Pacific Founders, announced a strategic partnership with Northern Westchester Ophthalmology, ... expands SightMD’s leading position in New York, adding the Company’s first location in ...
(Date:6/19/2019)... Va. (PRWEB) , ... June 19, 2019 , ... ... that have demonstrated their ability to meet rigorous national standards of performance continues ... has awarded national initial accreditation status to 11 local governmental public health departments. ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... ... 26th annual International Research Congress (IRC) in Marseille, France. The conference is ... state-of-the-art research on facioscapulohumeral muscular dystrophy (FSHD). Nearly 200 researchers, clinicians, industry representatives ...
(Date:6/18/2019)... ... 2019 , ... EMulate Therapeutics, Inc. , a clinical-stage ... it has received notice that the US Food and Drug Administration (FDA) accepted ... Hælo Pediatric system. The FDA granted the Humanitarian Use Device (HUD) designation ...
(Date:6/18/2019)... ... June 18, 2019 , ... ... outcomes, today announced Steve Einig has joined the organization in the newly created ... corporate initiatives around market engagement, marketing, strategic events and brand management. , “Steve ...
Breaking Medicine News(10 mins):